PT Inquest is an online journal club. Hosted by Jason Tuori, Megan Graham, and Chris Juneau, the show looks at an article every week and discusses how it applies to current physical therapy practice.
…
continue reading
Innhold levert av Oncology Times. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Oncology Times eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
Player FM - Podcast-app
Gå frakoblet med Player FM -appen!
Gå frakoblet med Player FM -appen!
Artificial Intelligence Tool Predicts Postoperative Radiotherapy Lymphedema
Manage episode 412750793 series 1021077
Innhold levert av Oncology Times. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Oncology Times eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
Artificial intelligence is being harnessed by a team of researchers at Leicester University in the United Kingdom to predict the risk of lymphedema (and potentially other toxicities) from the use of postoperative radiation therapy for breast cancer.
The 2024 European Breast Cancer Conference heard the latest news on an artificial intelligence tool that promises to help cancer clinicians individualize radiotherapy regimens after surgery to minimize toxicity.
Tim Rattay, MBChB, PhD, Associate Professor in Breast Surgery in the Leicester Cancer Research Centre at the University of Leicester and Consultant Breast Surgeon at the University Hospitals of Leicester in the UK, told the conference about his group’s machine-learning algorithm, PRE-ACT (Prediction of Radiotherapy side Effects using explainable AI for patient Communication and Treatment modification), that predicts post-operative lymphedema.
After reporting his research in Milan, Rattay called into the OncTimesTalk studio to give Peter Goodwin the details.
…
continue reading
The 2024 European Breast Cancer Conference heard the latest news on an artificial intelligence tool that promises to help cancer clinicians individualize radiotherapy regimens after surgery to minimize toxicity.
Tim Rattay, MBChB, PhD, Associate Professor in Breast Surgery in the Leicester Cancer Research Centre at the University of Leicester and Consultant Breast Surgeon at the University Hospitals of Leicester in the UK, told the conference about his group’s machine-learning algorithm, PRE-ACT (Prediction of Radiotherapy side Effects using explainable AI for patient Communication and Treatment modification), that predicts post-operative lymphedema.
After reporting his research in Milan, Rattay called into the OncTimesTalk studio to give Peter Goodwin the details.
156 episoder
Manage episode 412750793 series 1021077
Innhold levert av Oncology Times. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Oncology Times eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
Artificial intelligence is being harnessed by a team of researchers at Leicester University in the United Kingdom to predict the risk of lymphedema (and potentially other toxicities) from the use of postoperative radiation therapy for breast cancer.
The 2024 European Breast Cancer Conference heard the latest news on an artificial intelligence tool that promises to help cancer clinicians individualize radiotherapy regimens after surgery to minimize toxicity.
Tim Rattay, MBChB, PhD, Associate Professor in Breast Surgery in the Leicester Cancer Research Centre at the University of Leicester and Consultant Breast Surgeon at the University Hospitals of Leicester in the UK, told the conference about his group’s machine-learning algorithm, PRE-ACT (Prediction of Radiotherapy side Effects using explainable AI for patient Communication and Treatment modification), that predicts post-operative lymphedema.
After reporting his research in Milan, Rattay called into the OncTimesTalk studio to give Peter Goodwin the details.
…
continue reading
The 2024 European Breast Cancer Conference heard the latest news on an artificial intelligence tool that promises to help cancer clinicians individualize radiotherapy regimens after surgery to minimize toxicity.
Tim Rattay, MBChB, PhD, Associate Professor in Breast Surgery in the Leicester Cancer Research Centre at the University of Leicester and Consultant Breast Surgeon at the University Hospitals of Leicester in the UK, told the conference about his group’s machine-learning algorithm, PRE-ACT (Prediction of Radiotherapy side Effects using explainable AI for patient Communication and Treatment modification), that predicts post-operative lymphedema.
After reporting his research in Milan, Rattay called into the OncTimesTalk studio to give Peter Goodwin the details.
156 episoder
כל הפרקים
×Velkommen til Player FM!
Player FM scanner netter for høykvalitets podcaster som du kan nyte nå. Det er den beste podcastappen og fungerer på Android, iPhone og internett. Registrer deg for å synkronisere abonnement på flere enheter.